Status:
UNKNOWN
A Multi-dimensional Prospective Study to Discover Gene-microenvironment Interactions in Neurodevelopmental Disorders
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Attention-Deficit Hyperactivity Disorder, Unspecified Type
Autism Spectrum Disorder
Eligibility:
All Genders
5-18 years
Brief Summary
This project is the first involving the two most common neurodevelopmental disorders, ASD and ADHD, as well as TDC to establish a multi-dimensional database (clinic, behavior, neurocognitive function,...
Detailed Description
Autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD) are common neurodevelopmental disorders in Taiwan and worldwide (prevalence rate, ASD, 1%; ADHD, 3-10%), presenting a...
Eligibility Criteria
Inclusion
- Clinical diagnosis of autism spectrum disorder or attention-deficit hyperactivity disorder defined by the DSM-5 criteria, made by board-certificated child psychiatrists
- Ages range from 5 to 18
- Both parents are Han Chinese
- Subjects and their parents consented to have repeated assessments at 2 to 3 years later
Exclusion
- Comorbidity with DSM-5 diagnoses of ADHD (TDC group), ASD (ADHD and TDC groups), schizophrenia, schizoaffective disorder, delusional disorder, other psychotic disorders, organic psychosis, schizotypal personality disorder, bipolar disorder, depression, severe anxiety disorders or substance use
- Comorbidity with neurological or systemic disorders
- Having a first degree relative who may have ASD based on family history method assessment (ADHD and TDC groups)
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT04878575
Start Date
January 1 2021
End Date
December 1 2025
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan Univeristy Hospital
Taipei, Taiwan